KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 192 filers reported holding KITE PHARMA INC in Q4 2016. The put-call ratio across all filers is 2.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $24,165,000 | +1807.3% | 134,394 | +732.7% | 0.04% | +1700.0% |
| Q1 2017 | $1,267,000 | -86.2% | 16,140 | -90.2% | 0.00% | -86.7% |
| Q3 2016 | $9,161,000 | +299.0% | 164,000 | +228.0% | 0.02% | +150.0% |
| Q1 2016 | $2,296,000 | -42.4% | 50,000 | -22.7% | 0.01% | -25.0% |
| Q4 2015 | $3,986,000 | +175.3% | 64,686 | +148.8% | 0.01% | +166.7% |
| Q3 2015 | $1,448,000 | +22.9% | 26,000 | +34.6% | 0.00% | +50.0% |
| Q2 2015 | $1,178,000 | -48.9% | 19,318 | -51.7% | 0.00% | -60.0% |
| Q4 2014 | $2,307,000 | – | 40,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|